{"filing":{"accession_number":"0001575872-26-000516","cik":"0001135951","ticker":"RDY","company_name":"DR REDDYS LABORATORIES LTD","form":"6-K","filing_date":"2026-07-22","report_date":null,"primary_document":"rdy0921_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1135951/000157587226000516/rdy0921_6k.htm"},"events":[{"id":19366,"run_id":17427,"accession_number":"0001575872-26-000516","anchor_item_number":"EX-99.1","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"The exhibit discloses the appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel, effective July 22, 2026, with induction into the Management Council. This is a senior executive appointment that would materially affect investor assessment of the company's leadership and strategic direction in its biologics division. The secondary disclosure of the auditor appointment (Deloitte Haskins \u0026 Sells, LLP) is a routine auditor change that does not override the primary event.","company_name":"DR REDDYS LABORATORIES LTD","ticker":"RDY","filing_date":"2026-07-22","form":"6-K","submitted_at":null,"items":[{"id":18439,"accession_number":"0001575872-26-000516","item_number":"EX-99.1","item_title":"rdy0921_ex99-1.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The exhibit discloses the appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel, effective July 22, 2026, with induction into the Management Council. This is a senior executive appointment that would materially affect investor assessment of the company's leadership and strategic direction in its biologics division. The secondary disclosure of the auditor appointment (Deloitte Haskins \u0026 Sells, LLP) is a routine auditor change that does not override the primary event.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-22T12:31:48.007250+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":18439,"accession_number":"0001575872-26-000516","item_number":"EX-99.1","item_title":"rdy0921_ex99-1.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The exhibit discloses the appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel, effective July 22, 2026, with induction into the Management Council. This is a senior executive appointment that would materially affect investor assessment of the company's leadership and strategic direction in its biologics division. The secondary disclosure of the auditor appointment (Deloitte Haskins \u0026 Sells, LLP) is a routine auditor change that does not override the primary event.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-22T12:31:48.007250+00:00","company_name":"DR REDDYS LABORATORIES LTD","ticker":"RDY","filing_date":"2026-07-22"}]}